(0.03%) 5 208.25 points
(0.08%) 39 027 points
(-0.16%) 18 167 points
(-0.40%) $78.17
(0.64%) $2.21
(-0.36%) $2 322.90
(-0.38%) $27.51
(-0.04%) $964.55
(0.07%) $0.929
(0.39%) $10.87
(0.17%) $0.797
(-0.12%) $91.24
-1.18% $ 0.167
@ $0.190
Wydano: 6 vas. 2024 @ 18:13
Zwrot: -11.95%
Live Chart Being Loaded With Signals
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 102 891 |
Średni wolumen | 484 216 |
Kapitalizacja rynkowa | 3.92M |
EPS | $-0.110 ( 2024-04-15 ) |
Następna data zysków | ( $-0.160 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0900 |
ATR14 | $0.00100 (0.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Schneid Yair | Sell | 0 | Common Stock |
2023-08-04 | Stankovich Thomas | Sell | 108 | Common Stock, $0.001 par value per share |
2023-08-24 | Stankovich Thomas | Sell | 39 | Common Stock, $0.001 par value per share |
2023-09-01 | Stankovich Thomas | Sell | 118 | Common Stock, $0.001 par value per share |
2023-10-11 | Stankovich Thomas | Sell | 39 | Common Stock, $0.001 par value per share |
INSIDER POWER |
---|
-2.76 |
Last 95 transactions |
Buy: 10 386 223 | Sell: 2 711 639 |
Wolumen Korelacja
ReShape Lifesciences Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
LGVN | 0.931 |
PAIC | 0.919 |
CNSP | 0.911 |
HJLIW | 0.908 |
AXDX | 0.903 |
PCSA | 0.902 |
AGRI | 0.901 |
KXIN | 0.901 |
DXYN | 0.901 |
EBIX | 0.898 |
10 Najbardziej negatywne korelacje | |
---|---|
NETE | -0.922 |
BRIVU | -0.914 |
AMRB | -0.906 |
STAY | -0.901 |
NVCN | -0.899 |
SILK | -0.897 |
MSDA | -0.896 |
CGEM | -0.895 |
RAVN | -0.893 |
TIOA | -0.89 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ReShape Lifesciences Inc Korelacja - Waluta/Towar
ReShape Lifesciences Inc Finanse
Annual | 2023 |
Przychody: | $8.68M |
Zysk brutto: | $5.55M (63.93 %) |
EPS: | $-1.910 |
FY | 2023 |
Przychody: | $8.68M |
Zysk brutto: | $5.55M (63.93 %) |
EPS: | $-1.910 |
FY | 2022 |
Przychody: | $11.24M |
Zysk brutto: | $6.80M (60.52 %) |
EPS: | $-108.90 |
FY | 2021 |
Przychody: | $13.60M |
Zysk brutto: | $8.35M (61.38 %) |
EPS: | $-250.16 |
Financial Reports:
No articles found.
ReShape Lifesciences Inc
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej